Maria Gemenetzi

Clinician Scientist

•

Charité

I am a neurologist and clinician scientist at Charité. Since 2019, I have been conducting clinical research focused on neurodegenerative diseases, particularly Alzheimer’s and Huntington’s disease. Within the CRC, my research focuses on the interplay between circadian dysfunction and innate immune alterations during the prodromal stages of Alzheimer's disease.

‍

The projects of

Maria Gemenetzi

C02

Targeting

Circadian immune dysfunction in prodromal stages of Alzheimer‘s disease

AD is preceded by disrupted circadian rhythms and immune dysfunction. Innate immune cells possess functional clocks, but how circadian disruption in these cells contributes to AD progression is unclear.

Circadian immune dysfunction in prodromal stages of Alzheimer‘s disease

AD is preceded by disrupted circadian rhythms and immune dysfunction. Innate immune cells possess functional clocks, but how circadian disruption in these cells contributes to AD progression is unclear.

The publications of

Maria Gemenetzi

No items found.